First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck
-
Narrated by:
-
By:
Featuring an interview with Prof Martin Reck, including the following topics:
- Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunotherapy and maintenance lurbinectedin/atezolizumab (0:00)
- Biology of small cell lung cancer and pharmacodynamics of systemic treatment (3:25)
- Considerations with maintenance therapy for ES-SCLC (9:31)
- Considerations with immunotherapy for ES-SCLC (13:12)
- Curability of SCLC with systemic therapy (15:17)
- Data with chemoimmunotherapy for patients with poor performance status (25:55)
- Future developments in therapy for SCLC (30:11)
- Rapid fire: Small Cell 101 (35:45)
CME information and select publications
adbl_web_anon_alc_button_suppression_t1
No reviews yet